Back to Authors

Auth, Doris

0009-0002-4693-4303

A5076166988 | I1320320070

Mayo Clinic

United States Food and Drug Administration

Citations 1

Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing

JAMA Network Open | March 29, 2019 | Volume: 2 | Issue: 3 | Pages: e191340

10.1001/jamanetworkopen.2019.1340 | PMID 30924899